You might assume that heart disease comes with obvious warning signs. Yet, one particularly troublesome type—structural heart disease (SHD)—often goes unnoticed. It tends to develop without causing the typical symptoms like chest pain or shortness of breath, leaving individuals unaware until it’s far too late.
However, a new AI-powered tool called Echonext is making waves in this field. By analyzing standard ECGs, it can identify heart issues that even seasoned cardiologists might overlook. So, that quick five-minute heart test you had? It could be revealing critical information—especially if AI is monitoring it.
What is structural heart disease, and why should we worry?
SHD involves defects in the heart’s wall, valves, or chambers. Some people are born with these conditions, while others might develop them over time. Alarmingly, they often remain undetected until serious incidents, like heart attacks or strokes, occur. For this reason, experts refer to SHD as a “hidden” heart disease. Even ECGs, which doctors commonly use, can miss these problems. That’s where Echonext steps in.
Echonext: AI that knows when to dig deeper
Developed by researchers from Columbia University and NewYork-Presbyterian, Echonext has been trained on over 1.2 million ECG and echocardiogram pairs from more than 230,000 patients. Its critical task? To determine when a patient’s ECG suggests that additional imaging, like an echocardiogram, is necessary.
“Echonext essentially leverages low-cost tests to pinpoint those who may need pricier diagnostics,” explained Dr. Pierre Elias, who led the study. The results? Quite remarkable.
Echonext outperforms human cardiologists
In various assessments, Echonext successfully flagged 77% of SHD cases using ECGs, while cardiologists managed only 64%. Even more impressive is that when tested on nearly 85,000 individuals, Echonext identified over 7,500 at high risk for undiagnosed SHD. Follow-ups revealed that 73% of those who underwent echocardiograms were indeed found to have SHD—a significantly higher rate than average. This groundbreaking work was highlighted in Nature, a respected scientific journal. It’s more than just a sophisticated test; it’s potentially lifesaving.
Why is Echonext so crucial right now?
Every day, countless individuals are living with undiagnosed SHD, often skipping heart screenings because they feel fine. Even if they get an ECG, subtle signs may go unnoticed. Here’s where Echonext shines—it doesn’t tire or lose focus. This isn’t about replacing doctors; it’s about equipping them with powerful new tools to help catch what has previously slipped by.
What does this mean for you?
You don’t need to wait for symptoms to prioritize your heart health. If you’ve recently had an ECG, AI could help your doctor identify hidden risks they might miss. Tools like Echonext can uncover heart issues earlier, even if you’re feeling good.
The benefit? Fewer surprises, missed diagnoses, and a better chance at effective treatment before it’s too late. It’s not about taking away the physician’s role; it’s about enhancing their ability to detect problems early on. Ask your doctor if they’re incorporating AI tools like Echonext to analyze your heart tests. You deserve every possible advantage. Currently, Echonext is being used primarily in research, but its application is swiftly expanding into hospitals and clinics.
Key insights
AI isn’t just the future of medicine; it’s happening now. Echonext demonstrates how machine learning can fundamentally enhance our ability to identify silent threats like SHD. If something as simple as an ECG paired with AI can save lives, it raises the question: what are we waiting for?
